Q&A: The case for an intranasal COVID-19 vaccine

qa the case for an intranasal covid 19 vaccine

Sumary of Q&A: The case for an intranasal COVID-19 vaccine:

  • July 22, 2021 2 min read Source/Disclosures Published by: Source: Healio Interview.
  • Disclosures: Randall reports being a consultant for and receiving research funding from Altimmune.
  • Back to Healio According to scientists from the University of Alabama at Birmingham, only a small number of COVID-19 vaccines in development are given as nasal sprays, despite the technology’s potential to block SARS-CoV-2 transmission at the source.
  • it seems surprising that only seven of the nearly 100 SARS-CoV-2 vaccines currently in clinical trials are delivered intranasally,” Frances Lund, PhD, and Troy D.
  • Randall, PhD, wrote in a viewpoint published today in Science.
  • It may — depending on regulatory approval — mean that vaccines could be administered by oneself or by someone who is not trained to perform intramuscular injections.
  • That might make it easier to distribute and administer the vaccines.
  • Some aspects of the immune response occur locally, and having immunity in the nose should better protect against respiratory infection.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.